Senores Pharmaceuticals Limited announced the proceedings of its Extra-Ordinary General Meeting (EGM) held on Saturday, January 31, 2026. The meeting commenced at 12:30 P.M. (IST) and concluded at 12:55 P.M. (IST) via Video Conferencing (VC) / Other Audio Visual Means (OAVM). The primary business transacted at the EGM was the approval of the issuance of 11,70,000 Convertible Equity Warrants through a Preferential Issue on a private placement basis to persons belonging to the Promoter and Promoter group category. This resolution was passed as a Special Resolution. The meeting was attended by key management personnel including Mr. Sanjay Majmudar (Chairman), Mr. Swapnil Shah (Managing Director), and other Directors. The Secretarial Auditor and Scrutinizer, Mr. Mukesh H. Shah, also attended. Forty-eight members participated in the meeting. Details regarding remote e-voting were provided, which commenced on January 28, 2026, and concluded on January 30, 2026. An e-voting facility was also available during and immediately after the EGM. The company will submit the voting results separately in due course as per SEBI Listing Regulations. The proceedings of the EGM will be available on the company's website.
